ALTERNATIVE SPLICING OF CONTACTILE PROTEIN GENES
接触蛋白基因的选择性剪接
基本信息
- 批准号:3157778
- 负责人:
- 金额:$ 11.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1986
- 资助国家:美国
- 起止时间:1986-01-01 至 1990-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Alkali myosin light chain (MLC1/3), Alpha-tropomyosin (Alpha-TM) and
troponin T (TNT) are three genes expressed in sarcomeric muscles. Each one
of these genes generates multiple mRNAs, each coding for a different
protein isoform, by a process of alternative splicing. In the case of the
MLC1/3 gene, two alternatively spliced mRNAs (coding for MLC1 and MLC3,
respectively) are produced from two different and overlapping
transcriptional units whose promoters are located 10kb apart but terminate
at the same poly A addition site. The Alpha-TM gene produces a minimum of
three difference mRNAs that are alternatively spliced at both the 5' and 3'
ends. It is possible that the conformation of primary transcript with
differences at either the 5' end, the 3' end or both, is responsible for
the splice site selection that determines the alternative splicing
pathways. Troponin T on the other hand, produces a minimum of 10 different
mRNAs, with the potential to generate up to 64, with identical 5' and 3'
ends by alternative splicing of internal exons from a unique primary
transcript. Since the expression of these different TNT mRNA isoforms is
developmental and tissue-specific, it is likely that cell-specific
diffusable factors are involved in the regulation of the splicing pathways
of this single primary transcript.
The specific aims of this proposal are three fold: 1) To determine the
relative role of the structure of primary transcripts and putative
trans-acting factors in the production of regulated alternative splicing
pattern in muscle cells. 2) Using specific gene constructs, to determine
the cell and/or gene-specificity of the trans-acting factors involved in
alternative splicing by studying their expression in muscle and non-muscle
cells. 3) To initiate the characterization of these factors using in vitro
and in vivo splicing systems.
碱性肌球蛋白轻链(MLC1/3)、α-原肌球蛋白(Alpha-TM)和
肌钙蛋白T(TnT)是在肌肉中表达的三个基因。每一个都是
这些基因产生多个mRNAs,每个mRNAs编码一个不同的
蛋白质异构体,通过选择性剪接过程。在这种情况下
MLC1/3基因,两个交替剪接的mRNAs(编码MLC1和MLC3,
分别)是由两个不同且重叠的
启动子相距10kb但终止的转录单位
在相同的聚A加成部位。Alpha-TM基因产生最低限度的
在5‘和3’端交替剪接的三个差异mRNA
结束了。初级转录产物的构象可能与
在5‘端、3’端或两者之间的差异是导致
确定替代拼接的拼接位置选择
小路。另一方面,肌钙蛋白T至少产生10种不同的
有潜力产生高达的mRNA,具有相同的5‘和3’
末端由来自唯一的初级基因的内部外显子的选择性拼接而成
文字记录。由于这些不同的TNT mRNA亚型的表达是
发育和组织特异性,很可能是细胞特异性
可扩散因子参与剪接通路的调节
这份主要的成绩单。
这项建议的具体目标有三个方面:1)确定
初级转录本的结构和推测的相对作用
调控选择性剪接产生中的反式作用因素
肌肉细胞中的模式。2)使用特定的基因结构,以确定
参与的反式作用因子的细胞和/或基因特异性
通过研究它们在肌肉和非肌肉中的表达来实现选择性剪接
细胞。3)启动这些因子的体外表征
以及体内的剪接系统。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bernardo Nadal Ginard其他文献
Bernardo Nadal Ginard的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bernardo Nadal Ginard', 18)}}的其他基金
NHLBI SHARED RESEARCH FACILITY FOR MOLECULAR BIOLOGY
NHLBI 分子生物学共享研究设施
- 批准号:
3003468 - 财政年份:1987
- 资助金额:
$ 11.61万 - 项目类别:
ALTERNATIVE SPLICING OF CONTRACTILE PROTEIN GENES
收缩蛋白基因的选择性剪接
- 批准号:
3157783 - 财政年份:1986
- 资助金额:
$ 11.61万 - 项目类别:
ALTERNATIVE SPLICING OF CONTRACTILE PROTEIN GENES
收缩蛋白基因的选择性剪接
- 批准号:
3157779 - 财政年份:1986
- 资助金额:
$ 11.61万 - 项目类别:
ALTERNATIVE SPLICING OF CONTRACTILE PROTEIN GENES
收缩蛋白基因的选择性剪接
- 批准号:
3157785 - 财政年份:1986
- 资助金额:
$ 11.61万 - 项目类别:
ALTERNATIVE SPLICING OF CONTRACTILE PROTEIN GENES
收缩蛋白基因的选择性剪接
- 批准号:
2079165 - 财政年份:1986
- 资助金额:
$ 11.61万 - 项目类别:
ALTERNATIVE SPLICING OF CONTRACTILE PROTEIN GENES
收缩蛋白基因的选择性剪接
- 批准号:
3157782 - 财政年份:1986
- 资助金额:
$ 11.61万 - 项目类别:
ALTERNATIVE SPLICING OF CONTRACTILE PROTEIN GENES
收缩蛋白基因的选择性剪接
- 批准号:
3157781 - 财政年份:1986
- 资助金额:
$ 11.61万 - 项目类别:
ALTERNATIVE SPLICING OF CONTRACTILE PROTEIN GENES
收缩蛋白基因的选择性剪接
- 批准号:
3157780 - 财政年份:1986
- 资助金额:
$ 11.61万 - 项目类别:
ALTERNATIVE SPLICING OF CONTRACTILE PROTEIN GENES
收缩蛋白基因的选择性剪接
- 批准号:
3157784 - 财政年份:1986
- 资助金额:
$ 11.61万 - 项目类别:
相似海外基金
CAREER: Elucidating spatial and epigenetic regulation of gene expression during human development using photopatterning and single-cell multiomics
职业:利用光模式和单细胞多组学阐明人类发育过程中基因表达的空间和表观遗传调控
- 批准号:
2339849 - 财政年份:2024
- 资助金额:
$ 11.61万 - 项目类别:
Continuing Grant
CAREER: Scalable algorithms for regularized and non-linear genetic models of gene expression
职业:基因表达的正则化和非线性遗传模型的可扩展算法
- 批准号:
2336469 - 财政年份:2024
- 资助金额:
$ 11.61万 - 项目类别:
Continuing Grant
CAREER: Epigenetic Regulation of Gene Expression in Engineered Prokaryotes
职业:工程原核生物基因表达的表观遗传调控
- 批准号:
2338573 - 财政年份:2024
- 资助金额:
$ 11.61万 - 项目类别:
Continuing Grant
MFB: RNA modifications of frameshifting stimulators: cellular platforms to engineer gene expression by computational mutation predictions and functional experiments
MFB:移码刺激器的RNA修饰:通过计算突变预测和功能实验来设计基因表达的细胞平台
- 批准号:
2330628 - 财政年份:2024
- 资助金额:
$ 11.61万 - 项目类别:
Standard Grant
22-BBSRC/NSF-BIO Building synthetic regulatory units to understand the complexity of mammalian gene expression
22-BBSRC/NSF-BIO 构建合成调控单元以了解哺乳动物基因表达的复杂性
- 批准号:
BB/Y008898/1 - 财政年份:2024
- 资助金额:
$ 11.61万 - 项目类别:
Research Grant
How does the chromatin remodeller CHD4 regulate gene expression?
染色质重塑因子 CHD4 如何调节基因表达?
- 批准号:
DP240102119 - 财政年份:2024
- 资助金额:
$ 11.61万 - 项目类别:
Discovery Projects
Data-driven model links BMIz to gene expression in pediatric asthma
数据驱动模型将 BMIz 与小儿哮喘基因表达联系起来
- 批准号:
493135 - 财政年份:2023
- 资助金额:
$ 11.61万 - 项目类别:
Regulation of gene expression by the La and La-related proteins
La 和 La 相关蛋白对基因表达的调节
- 批准号:
489704 - 财政年份:2023
- 资助金额:
$ 11.61万 - 项目类别:
Operating Grants
Investigating the role of SARS-CoV-2 and MERS-CoV transcription regulatory sequence (TRS) in viral gene expression and virulence
研究 SARS-CoV-2 和 MERS-CoV 转录调控序列 (TRS) 在病毒基因表达和毒力中的作用
- 批准号:
494272 - 财政年份:2023
- 资助金额:
$ 11.61万 - 项目类别:
Operating Grants
Application for 2024 CIHR NIF (ECR): Investigating the role of SARS-CoV-2 and MERS-CoV transcription regulatory sequence (TRS) in viral gene expression and virulence
2024 CIHR NIF (ECR) 申请:研究 SARS-CoV-2 和 MERS-CoV 转录调控序列 (TRS) 在病毒基因表达和毒力中的作用
- 批准号:
491942 - 财政年份:2023
- 资助金额:
$ 11.61万 - 项目类别: